Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 14/20 | 0.46 |
| ▸ | TYK2 | P29597 | 1/20 | 0.39 |
| ▸ | CTSC | P53634 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL415554 | 0.88 | SLC2A1 (0.46) | TYK2SLC2A1 | |
| SCHEMBL415553 | 0.88 | SLC2A1 (0.46) | TYK2SLC2A1 | |
| SCHEMBL412716 | 0.87 | CHRNA7 (0.48) | CHRNA7TYK2CTSC | |
| SCHEMBL412717 | 0.87 | CHRNA7 (0.48) | CHRNA7TYK2CTSC | |
| SCHEMBL10242564 | 0.87 | CHRNA7 (0.48) | CHRNA7TYK2CTSC | |
| SCHEMBL414775 | 0.82 | CHRNA7 (0.51) | CHRNA7TYK2 | |
| SCHEMBL414776 | 0.82 | CHRNA7 (0.51) | CHRNA7TYK2 | |
| SCHEMBL10242560 | 0.82 | CHRNA7 (0.51) | CHRNA7TYK2 | |
| SCHEMBL17836745 | 0.81 | CHRNA7 (0.39) | CHRNA7CTSCSLC2A1 | |
| SCHEMBL17836746 | 0.81 | CHRNA7 (0.39) | CHRNA7CTSCSLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2595965-A1 | INSECTICIDAL TRIAZINES AND PYRIMIDINES | Vestaron Corporation (US) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012012528-A1 | INSECTICIDAL TRIAZINES AND PYRIMIDINES | Vestaron Corporation (US) | 2012-01-26 | — | — | WO | disclosed |